| AD |
Alzheimer’s Disease |
| AIDS |
Acquired Immunodeficiency Syndrome |
| ART |
Antiretroviral therapy |
| CE |
Capillary Electrophoresis |
| CE-MS |
Capillary Electrophoresis–Mass Spectrometry |
| CID |
Collision-Induced Dissociation |
| DKD |
Diabetic Kidney Disease |
| DR |
Diabetic Retinopathy |
| EI |
Electron Ionization |
| ESI |
Electrospray Ionization |
| ESI-MS |
Electrospray Ionization Mass Spectrometry |
| ESI-MS/MS |
Electrospray Ionization Tandem Mass Spectrometry |
| ESI-QTOF |
Electrospray Ionization Quadrupole Time-of-Flight Mass Spectrometry |
| GC |
Gas Chromatography |
| GC×GC |
Comprehensive Two-dimensional Gas Chromatography |
| GC-MS |
Gas Chromatography–Mass Spectrometry |
| GC-MS/MS |
Gas Chromatography–Tandem Mass Spectrometry |
| GDM |
Gestational Diabetes Mellitus |
| HCV |
Hepatitis C Virus |
| HDL |
High-Density Lipoprotein |
| HF |
Heart Failure |
| HIV |
Human Immunodeficiency Virus |
| HPLC |
High-Performance Liquid Chromatography |
| HPLC-MS |
High-Performance Liquid Chromatography–Mass Spectrometry |
| HPLC-MS/MS |
High-Performance Liquid Chromatography–Tandem Mass Spectrometry |
| ICU |
Intense Care Unit |
| LC |
Liquid Chromatography |
| LC-MS |
Liquid Chromatography–Mass Spectrometry |
| LC-MS/MS |
Liquid Chromatography–Tandem Mass Spectrometry |
| LDL |
Low-Density Lipoprotein |
| LN |
Lupus Nephritis |
| LPC |
Lysophosphatidylcholine |
|
m/z
|
Mass-to-Charge Ratio |
| MRM |
Multiple Reaction Monitoring |
| MRM-MS |
Multiple Reaction Monitoring Mass Spectrometry |
| MS |
Mass Spectrometry |
| MS/MS |
Tandem Mass Spectrometry |
| NAFL |
Nonalcoholic Fatty Liver |
| NAFLD |
Non-alcoholic Fatty Liver Disease |
| NASH |
Nonalcoholic steatohepatitis |
| PC |
Phosphatidylcholine |
| PCOS |
Polycystic Ovary Syndrome |
| PCT |
Procalcitonin |
| PDR |
Proliferative Diabetic Retinopathy |
| QQQ |
Triple Quadrupole |
| QTOF |
Quadrupole Time-of-Flight |
| RA |
Rheumatoid Arthritis |
| RYGB |
Roux-en-Y Gastric Bypass |
| SLE |
Systemic Lupus Erythematosus |
| SM |
Sphingomyelin |
| SRM |
Selected Reaction Monitoring |
| T1D |
Type 1 Diabetes |
| T2D |
Type 2 Diabetes |
| TCA |
Tricarboxylic Acid |
| TNF-
|
Tumour Necrosis Factor alpha |
| TOF |
Time-of-Flight |
| TOF-MS |
Time-of-Flight Mass Spectrometry |
| UHPLC |
Ultra-High-Performance Liquid Chromatography |
| UHPLC-MS/MS |
Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry |
| UPLC |
Ultra Performance Liquid Chromatography |
| UPLC-Q-TOF-MS |
Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry |
| WHO |
World Health Organization |